OTC:RGBP | Free Cash Flow | Regen BioPharma Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$197,941.00
2025-09-30-$160,005.00
2024-12-31-$66,379.00
2024-09-30-$207,289.00
2023-12-31-$162,336.00
2023-09-30-$23,405.00
2022-12-31-$10,463.00
2022-09-30-$85,287.00
2021-12-31-$279,135.00
2021-09-30-$1.07M
2020-12-31$0.00
2020-09-30$0.00
2019-12-31$24,302.00
2019-09-30-$136,964.00
2018-12-31-$150,032.00
2018-09-30-$465,636.00
2017-12-31-$627,265.00
2017-09-30-$623,017.00
2016-12-31-$504,295.00
2016-09-30-$398,495.00
2015-12-31-$425,403.00
2015-09-30-$338,962.00
2014-12-31-$197,103.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$383,591.00
2024-09-30-$751,536.00
2023-09-30-$173,917.00
2022-09-30-$606,921.00
2021-09-30-$1.13M
2020-09-30$18,645.00
2019-09-30-$481,792.00
2018-09-30-$1.58M
2017-09-30-$1.89M
2016-09-30-$1.67M
2015-09-30-$1.19M